{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"ARS Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"SPRY"},"Address":{"label":"Address","value":"500 FAIRVIEW AVENUE N,SUITE 600 SUITE 120, SEATTLE, Washington, 98109, United States"},"Phone":{"label":"Phone","value":"+1 206 456-2900"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications, and insect bites that could lead to life-threatening anaphylaxis."},"CompanyUrl":{"label":"Company Url","value":"https://www.ars-pharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Brian T. Dorsey","title":"Chief Operating Officer"},{"name":"Richard E. Lowenthal","title":"President, Chief Executive Officer & Director"},{"name":"Robert Bell","title":"Chief Science Officer"},{"name":"Sarina Tanimoto","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}